Evidence‑Based Diagnostic Approach for Heart Failure

Clinical Assessment

Typical symptoms (e.g., exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, exercise‑limiting fatigue, bilateral peripheral edema) must be combined with objective cardiac evaluation; symptoms alone are insufficient for diagnosis. 1
Specific physical signs that increase suspicion (elevated jugular venous pressure, third heart sound (S3), hepato‑jugular reflux, lateral displacement of the apical impulse) are useful but have poor correlation with the severity of cardiac dysfunction and should not be used as the sole diagnostic criterion. 2, 3

Mandatory Initial Tests

12‑Lead Electrocardiogram (ECG)

A 12‑lead ECG should be obtained in all patients with suspected heart failure. 4, 1
A completely normal ECG provides a negative predictive value > 90 % for left‑ventricular systolic dysfunction, making heart failure highly unlikely. 2, 1, 3
When the ECG is normal, clinicians should seriously reconsider the heart‑failure diagnosis. 2, 3

Chest Radiography (PA + Lateral)

Chest X‑ray identifies cardiomegaly and pulmonary congestion, supporting the diagnostic work‑up. 4, 2, 3

Laboratory Panel (baseline)

Required baseline tests include: complete blood count, serum electrolytes (including calcium and magnesium), renal function (creatinine ± blood urea nitrogen), fasting glucose, liver‑function tests, thyroid‑stimulating hormone, fasting lipid profile, and urinalysis. These investigations help identify comorbidities and potential reversible contributors. 4, 2, 3

Echocardiography with Doppler (Gold Standard)

Transthoracic echocardiography is the definitive test for confirming heart failure; it provides the essential objective evidence of cardiac dysfunction required for diagnosis. 2, 1, 3
The study quantifies left‑ventricular ejection fraction (LVEF) to differentiate reduced‑EF (< 45‑50 %) from preserved‑EF (≥ 45‑50 %) phenotypes and evaluates ventricular size, wall thickness, valvular function, and diastolic filling patterns. 4, 2, 3

Natriuretic Peptide Testing (BNP/NT‑proBNP)

Measurement of BNP or NT‑proBNP is recommended when the clinical diagnosis remains uncertain after the initial assessment. 4, 1
Elevated peptide levels indicate the need for confirmatory echocardiography and provide prognostic information regarding disease severity. 4
Current evidence does not support routine BNP/NT‑proBNP‑guided therapy for reducing hospitalizations or mortality. 4

Structured Diagnostic Algorithm (Key Evidence Points)

Selective Additional Tests (When Clinically Indicated)

Screening for hereditary iron overload (hemochromatosis), HIV infection, connective‑tissue disease, amyloidosis, or pheochromocytoma may be performed in appropriate clinical contexts. 4, 3

Exercise Testing

Maximal exercise testing has limited diagnostic value for confirming heart failure but a normal result can exclude the condition. 2, 3
It is useful for prognostic stratification and transplant evaluation in high‑risk patients.

Common Pitfalls to Avoid

Do not delay echocardiography; it is the definitive test and should be performed early to guide management.
Do not rely solely on symptoms; objective evidence (ECG, imaging, labs) is required. 1
Do not depend exclusively on chest radiography; its predictive value is limited without typical symptoms and an abnormal ECG. 2, 3
Do not use pulmonary function tests as primary diagnostic tools for heart failure; they are mainly useful to rule out respiratory causes. 2, 3

Diagnostic Criteria for Heart Failure

Clinical Assessment

The European Society of Cardiology recommends that the diagnosis of heart failure requires both typical symptoms (dyspnea, fatigue, peripheral edema) AND objective evidence of cardiac dysfunction, usually through echocardiography 5, 6
Typical symptoms include fatigue, dyspnea, and peripheral edema, though these are not specific to heart failure 5, 6
Initial examination should include assessment of volume status, orthostatic blood pressure changes, weight, height, and body mass index calculation 7, 8
A careful history should include current and past use of alcohol, illicit drugs, alternative therapies, and chemotherapy drugs 8
There is often poor correlation between symptoms and the severity of cardiac dysfunction 5, 6

Essential Diagnostic Tests

Echocardiography with Doppler is the cornerstone of diagnosis that provides objective evidence of cardiac dysfunction at rest, which is necessary for the diagnosis 5, 6
Echocardiography measures left ventricular ejection fraction (LVEF) to distinguish between systolic dysfunction and preserved systolic function 8
A 12-lead ECG should be performed in all patients with suspected heart failure, and a normal ECG makes heart failure diagnosis unlikely (negative predictive value >90%) 5, 6, 7, 8
Chest X-ray is part of initial workup to detect cardiomegaly and pulmonary congestion 5, 6
Laboratory tests, including complete blood count, urinalysis, serum electrolytes, blood urea nitrogen and creatinine, fasting blood glucose, lipid profile, liver function tests, and thyroid-stimulating hormone, are essential for initial evaluation 6, 7, 8
Natriuretic peptides (BNP and NT-proBNP) are useful when clinical diagnosis is uncertain, with high negative predictive value making them valuable as a "rule out" test 6, 8, 9

Classification of Heart Failure

Heart failure can be classified as heart failure with reduced ejection fraction (HFrEF): LVEF <45-50% or heart failure with preserved ejection fraction (HFpEF): LVEF ≥45-50% with evidence of diastolic dysfunction 10
Diastolic dysfunction can be assessed through E/A ratio, E/Ea ratio, deceleration time, and pulmonary vein flow 10, 11

Additional Tests in Selected Cases

Exercise testing has limited value for diagnosis but is useful for excluding heart failure, prognostic stratification, and determining if heart failure is the cause of exercise limitation 5, 6, 8, 9, 12
Coronary arteriography is recommended for patients with angina or significant ischemia, patients with chest pain of uncertain origin, and patients with known/suspected coronary artery disease without angina 7, 8
Specialized tests, such as screening for hemochromatosis, sleep-disturbed breathing, or HIV, and tests for rheumatologic diseases, amyloidosis, or pheochromocytoma, should be performed when clinically indicated 6, 8, 9

Diagnostic Algorithm

The diagnostic algorithm involves evaluating symptoms and signs, performing initial tests, measuring natriuretic peptides if clinical suspicion remains, confirming with echocardiography, determining if systolic or diastolic dysfunction, identifying underlying etiology, and classifying severity using NYHA functional classification 5, 6, 8, 9, 12

Diagnostic Evaluation of Heart Failure

Clinical Assessment

Elevated jugular venous pressure, a third heart sound, hepato‑jugular reflux, and lateral displacement of the apical impulse are key physical signs that raise suspicion for heart failure. ACC recommendation. 13
Assessment of volume status should include orthostatic blood‑pressure changes, body weight trends, and body‑mass‑index measurement. ACC recommendation. [14][15]
A thorough exposure history—covering alcohol use, illicit drug use, and cardiotoxic agents such as anthracyclines, trastuzumab, and cyclophosphamide—is essential for identifying reversible contributors. AHA and ACC recommendations. [16][14]15
Patient‑reported symptoms (dyspnea, orthopnea, fatigue, edema) correlate poorly with the severity of cardiac dysfunction and are insufficient alone for diagnosis. ESC statement. 17

Electrocardiography

A 12‑lead ECG must be performed in every individual with suspected heart failure. ACC guideline. [14][15]
A completely normal ECG has a negative predictive value > 90 % for excluding left‑ventricular systolic dysfunction; a normal result should prompt reconsideration of the diagnosis. ESC evidence. 17
An abnormal ECG supports further diagnostic work‑up but does not by itself confirm heart failure. ESC evidence. 17

Chest Radiography

Chest X‑ray (PA and lateral) should be obtained to look for cardiomegaly and pulmonary congestion. ACC recommendation. [14][15]
The radiograph’s predictive value is meaningful only when combined with typical heart‑failure symptoms and an abnormal ECG. ESC statement. 17

Baseline Laboratory Panel

Routine labs for all suspected cases include:
- Complete blood count – to detect anemia or infection. ACC. [14][15]17
- Serum electrolytes (including calcium, magnesium) – to identify disturbances affecting cardiac function. ACC. [14][15]
- Blood urea nitrogen and creatinine – to assess renal function. ACC. [14][15]
- Fasting glucose and glycated hemoglobin – to screen for diabetes. ACC. [14][15]
- Lipid profile – for cardiovascular risk stratification. ACC. [14][15]
- Liver‑function tests – to detect hepatic congestion or other liver disease. ACC. [14][15]
- Thyroid‑stimulating hormone – to uncover thyroid disorders that can mimic or exacerbate heart failure. AHA and ACC. [16][14]15
- Urinalysis – to evaluate for proteinuria or hematuria. ACC. [14][15]
- Fasting transferrin saturation – to screen for hemochromatosis. AHA. 16

Echocardiography (Definitive Imaging)

Comprehensive 2‑D echocardiography with Doppler is the gold‑standard test for confirming heart failure and must be performed early. ACC guideline. [13][14]15
The study must answer three core questions:
Additional Doppler assessments (mitral inflow, pulmonary‑venous flow, mitral annular velocity, tricuspid regurgitant gradient, inferior‑vena‑cava size) provide estimates of left‑ and right‑sided filling pressures. ACC. 13

Etiology Identification

Coronary artery disease accounts for roughly two‑thirds of heart‑failure cases with reduced ejection fraction. AHA data. 16
Coronary arteriography is mandatory for patients with angina or documented significant ischemia (when revascularization is a possibility). ACC recommendation. [14][15]
Coronary arteriography is reasonable for patients with chest pain of uncertain origin or known/suspected CAD without angina. ACC recommendation. [14][15]
Non‑invasive stress imaging (stress echocardiography or nuclear cardiology) is reasonable to detect ischemia and myocardial viability in known CAD. ACC recommendation. [14][15]
Other potential etiologies to screen for, based on clinical context:
- Valvular heart disease – evaluated on echocardiography. ACC. 13
- Hypertension. AHA. 16
- Familial cardiomyopathy – consider ECG and echo in first‑degree relatives. AHA. 16
- Thyroid disease – already screened with TSH. AHA/ACC. [16][14]15
- HIV infection – screen high‑risk patients. AHA/ACC. [16][14]15
- Hemochromatosis – confirmed with cardiac MRI if transferrin saturation is elevated. AHA. 16
- Sleep‑disordered breathing – evaluate in appropriate patients. AHA/ACC. [16][14]15
- Rheumatologic diseases, amyloidosis, pheochromocytoma – assess when clinically suspected. ACC. [14][15]

Additional Functional Testing

Exercise testing has limited diagnostic value for confirming heart failure; however, a normal maximal exercise test effectively excludes the diagnosis. ESC evidence. 17
Exercise testing is useful to determine whether heart failure contributes to exercise limitation when the cause is uncertain. ACC recommendation. [14][15]
Maximal exercise testing with respiratory gas exchange identifies high‑risk patients who may be candidates for transplant evaluation. ACC recommendation. [14][15]
Pulmonary function testing does not diagnose heart failure but helps exclude primary respiratory causes of dyspnea. ESC evidence. 17

Critical Pitfalls to Avoid

Always seek the underlying etiology (ischemic, valvular, hypertensive, etc.) rather than accepting “heart failure” as the final diagnosis. ESC. 17
Do not rely solely on symptoms; objective evidence of cardiac dysfunction is mandatory. ESC. 17
Do not skip echocardiography; clinical assessment alone is insufficient for diagnosis. ESC. 17
A completely normal ECG should prompt reconsideration of heart failure because of its excellent negative predictive value. ESC. 17
Chest radiography alone has limited predictive value; it must be interpreted together with typical symptoms and an abnormal ECG. ESC. 17